Posts by The Block Firm
Court Grants Final Approval to $46.5 Million Class Action Settlement
This month The Block Firm obtained final approval of a $46.5 million class action settlement, which will benefit over a million class members nationwide. The settlement, in the case of Faulkner v. Acella Pharmaceuticals (N.D. Ga.), resolves allegations that a drugmaker sold a defective thyroid medication on the basis of false advertising about the drug’s active ingredient.…
Read MoreThe Block Firm Files Class Action About Contaminated Drugs
This week The Block Firm, partnering with our good friends at Anderson & Shah, filed a class action (read complaint here) against the manufacturer of a generic form of Cymbalta (duloxetine). The defendant, Breckenridge Pharmaceutical, Inc., recalled more than 50 million pills because they were contaminated with nitrosamines. Nitrosamines are a known byproduct of unsafe…
Read MoreAttorney Max Marks Argues on behalf of Fitzgerald Fruit Farms in front of the Supreme Court of Georgia in Case Whitaker Farms LLC vs. Fitzgerald Farms LLC
On May 16, 2024 Max Marks argued on behalf of Fitzgerald Farms in front of the Supreme Court of Georgia, defending his victories at trial and before the court of appeals in Whitaker Farms, LLC vs. Fitzgerald Farms LLC, No. s23G1162. In that case, Max represents a family farmer whose crops were destroyed as a result of what two…
Read MoreFDA Recalls Duloxetine: The Block Firm continues to investigate
The U.S. Food and Drug Administration (FDA) has recently issued a recall for duloxetine, a medication commonly prescribed for depression and anxiety. If you or a loved one has been taking duloxetine, this news may be concerning. At The Block Firm, we understand the impact such recalls can have on your health and well-being. Our…
Read MoreThe Block Firm Investigates the Presence of Carcinogens in Duloxetine (Generic Cymbalta)
Millions of Americans take the drug duloxetine—a generic form of Cymbalta—for depression, pain, and anxiety. According to a recent FDA announcement, tens of millions of duloxetine tablets sold by Breckenridge Pharmaceutical, Inc. are being recalled because they are apparently contaminated with a carcinogen in the nitrosamine family. Drug regulators consider nitrosamines as “high potency mutagenic…
Read MoreThe Block Firm Investigates Unapproved Thyroid Drug, Adthyza
The Block Firm is investigating a new potential case regarding Adthyza, an unapproved thyroid drug manufactured by Azurity. At The Block Firm, we believe that patients are entitled to safe and effective medication. By refusing to seek FDA approval for Adthyza, Azurity refused to prove that this drug meets federal standards for safety, efficacy, and…
Read MoreUnapproved Prescription Drugs Are Rampant—and Can Harm Your Health.
Many Americans trust that prescription drugs have been approved by the Food & Drug Administration and are safe and effective for patients to take. After all, the U.S. health care industry is highly regulated, the FDA exists to police unsafe products, and multiple state and federal laws, starting with the Food, Drug & Cosmetic Act,…
Read MoreNeptune’s Fix Elixir Recalled by the FDA Due to Potentially Harmful Ingredient, Tianeptine
The Block Firm is investigating a potential class action lawsuit against Neptune’s Resources, LLC, the manufacturer of Neptune’s Fix Elixir, Neptune’s Fix Extra Strength Elixir, and Neptune’s Fix Tablets. These products were recalled by the FDA on January 28, 2024 due to the presence of tianeptine, a potentially dangerous substance that is illegally sold with…
Read MoreThe Block Firm Receives Preliminary Approval of $46.5 Million Class Action Settlement
Since 2022, The Block Firm has been pursuing a class action against Acella Pharmaceuticals, the manufacturer of NP Thyroid. The class action alleges that Acella knowingly distributed adulterated thyroid medication that did not contain the amount of active pharmaceutical ingredient Acella claimed. Improper dosing of thyroid medication can have serious health consequences, and the class…
Read MoreThe Block Firm Investigates a Potential Class Action Against MiMedx Group, Inc.
The Block Firm is investigating a potential class action lawsuit against MiMedx Group, Inc., the maker of the AXIOFILL wound treatment. According to a recently released FDA Warning Letter, MiMedx Group has been selling AXIOFILL without proper approval for safety and efficacy. Additionally, FDA determined that MiMedx Group has been violating federal safety standards known…
Read More